Machatha Stephen
- SEC CIK
- 0001836354
No open-market purchases or sales filed in the past year.
Current role at each company
- ALDX Aldeyra Therapeutics, Inc.Chief Development Officeras of Aug 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Machatha Stephen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Machatha StephenChief Development Officer | SSale | −22.1K | $5.15 | −$113.7K | −9.1%221.8K after | |
| Aug 14, 2024 (view filing) | Aug 12 | 2 days | Machatha StephenChief Development Officer | SSale | −16.0K | $4.74 | −$76.0K | −6.3%236.8K after | |
| Apr 17, 2024 (view filing) | Mar 12 | 36 days | Machatha StephenChief Development Officer | SSale | −11.5K | $3.16 | −$36.5K | −4.4%252.8K after | Amended |
| Mar 12, 2024 (view filing) | Mar 11 | 1 day | Machatha StephenChief Development Officer | SSale | −18.2K | $3.41 | −$62.2K | −6.7%255.0K after | From original |